Glycemia and levels of cerebrospinal fluid amyloid and tau in patients attending a memory clinic

Journal of the American Geriatrics Society

Volumn 58, Issue 7, 2010, Pages 1318-1321

  Exalto, Lieza G ^a   Van Der Flier, Wiesje M ^b,c   Scheltens, Phillip ^b   Biessels, Geert Jan ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^c VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

amyloid; dementia; glucose; HbA1c; tau

Indexed keywords

AMYLOID BETA PROTEIN[1-42]; BIOLOGICAL MARKER; HEMOGLOBIN A1C; MEMBRANE PROTEIN; PHOSPHORYLATED TAU AT THREONINE 181; TAU PROTEIN; UNCLASSIFIED DRUG;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; CLINICAL ASSESSMENT; COGNITIVE DEFECT; CROSS-SECTIONAL STUDY; DEMENTIA; DIABETES MELLITUS; FEMALE; GLUCOSE BLOOD LEVEL; HEMOGLOBIN BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; MILD COGNITIVE IMPAIRMENT; PROTEIN BLOOD LEVEL; PROTEIN CEREBROSPINAL FLUID LEVEL; PROTEIN METABOLISM;

AGED; ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; BLOOD GLUCOSE; COGNITION DISORDERS; CROSS-SECTIONAL STUDIES; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; MALE; MIDDLE AGED; OUTPATIENT CLINICS, HOSPITAL; PEPTIDE FRAGMENTS; RISK FACTORS; TAU PROTEINS;

EID: 77954331117     PISSN: 00028614     EISSN: 15325415     Source Type: Journal    
DOI: 10.1111/j.1532-5415.2010.02854.x     Document Type: Article

References (20)

1. Kloppenborg RP, van den Berg E, Kappelle LJ et al. Diabetes and other vascular risk factors for dementia: Which factor matters most? A systematic review. Eur J Pharmacol 2008 585 : 97 108.
2. Strachan MW, Deary IJ, Ewing FM et al. Is type II diabetes associated with an increased risk of cognitive dysfunction? A critical review of published studies. Diabetes Care 1997 20 : 438 445.
3. Alafuzoff I, Aho L, Helisalmi S et al. Beta-amyloid deposition in brains of subjects with diabetes. Neuropathol Appl Neurobiol 2009 35 : 60 68.
4. Craft S, Watson GS. Insulin and neurodegenerative disease: Shared and specific mechanisms. Lancet Neurol 2004 3 : 169 178.
5. Gasparini L, Xu H. Potential roles of insulin and IGF-1 in Alzheimer's disease. Trends Neurosci 2003 26 : 404 406.
6. Smith MA, Sayre LM, Monnier VM et al. Radical Ageing in Alzheimer's disease. Trends Neurosci 1995 18 : 172 176.
7. MacLullich AM, Deary IJ, Starr JM et al. Glycosylated hemoglobin levels in healthy elderly nondiabetic men are negatively associated with verbal memory. J Am Geriatr Soc 2004 52 : 848 849.
8. Gao L, Matthews FE, Sargeant LA et al. An investigation of the population impact of variation in HbA1c levels in older people in England and Wales: From a population based multi-centre longitudinal study. BMC Public Health 2008 8 : 54.
9. Enzinger C, Fazekas F, Matthews PM et al. Risk factors for progression of brain atrophy in aging: Six-year follow-up of normal subjects. Neurology 2005 64 : 1704 1711.
10. McKhann G, Drachman D, Folstein M et al. Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984 34 : 939 944.
11. Petersen RC, Doody R, Kurz A et al. Current concepts in mild cognitive impairment. Arch Neurol 2001 58 : 1985 1992.
12. Bouwman FH, van der Flier WM, Schoonenboom NS et al. Longitudinal changes of CSF biomarkers in memory clinic patients. Neurology 2007 69 : 1006 1011.
13. Takeuchi M, Yamagishi S. Possible involvement of advanced glycation end-products (AGEs) in the pathogenesis of Alzheimer's disease. Curr Pharm Des 2008 14 : 973 978.
14. Shuvaev VV, Laffont I, Serot JM et al. Increased protein glycation in cerebrospinal fluid of Alzheimer's disease. Neurobiol Aging 2001 22 : 397 402.
15. Vitek MP, Bhattacharya K, Glendening JM et al. Advanced glycation end products contribute to amyloidosis in Alzheimer disease. Proc Natl Acad Sci U S A 1994 91 : 4766 4770.
16. Ledesma MD, Bonay P, Colaco C et al. Analysis of microtubule-associated protein tau glycation in paired helical filaments. J Biol Chem 1994 269 : 21614 21619.
17. Akisaki T, Sakurai T, Takata T et al. Cognitive dysfunction associates with white matter hyperintensities and subcortical atrophy on magnetic resonance imaging of the elderly diabetes mellitus Japanese elderly diabetes intervention trial (J-EDIT). Diabetes Metab Res Rev 2006 22 : 376 384.
18. Arvanitakis Z, Schneider JA, Wilson RS et al. Diabetes is related to cerebral infarction but not to AD pathology in older persons. Neurology 2006 67 : 1960 1965.
19. Tapiola T, Alafuzoff I, Herukka SK et al. Cerebrospinal fluid [beta]-amyloid 42 and tau proteins as biomarkers of Alzheimer-type pathologic changes in the brain. Arch Neurol 2009 66 : 382 389.
20. Kester MI, van der Vlies AE, Blankenstein MA et al. CSF biomarkers predict rate of cognitive decline in Alzheimer disease. Neurology 2009 73 : 1353 1358.